VVOS Stock Catalyst: Vivos Therapeutics Granted New Patent

Vivos Therapeutics, Inc. (Nasdaq: VVOS) announced it has been granted a new patent by the United States Patent and Trademark Office. The patent enhances the company's intellectual property portfolio, providing additional protection for its innovative medical devices.

The newly granted patent covers specific aspects of Vivos Therapeutics' technology used in its devices. This addition to the company's patent portfolio is expected to support its competitive position in the medical device industry.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.